Transapical transcatheter mitral valve implantation with J-valve in patients with degenerated mitral bioprostheses.
J-valve
Transapical
Transcatheter mitral valve implantation
Valve-in-valve
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
10 08 2023
10 08 2023
Historique:
received:
11
05
2023
accepted:
24
07
2023
medline:
14
8
2023
pubmed:
11
8
2023
entrez:
10
8
2023
Statut:
epublish
Résumé
Due to the widespread application of bioprosthetic valve in the treatment of mitral valve disease in recent years, the incidence of valve failure has increased significantly, which is facing the need of reoperation. For high-risk patients, transcatheter mitral valve-in-valve placement is increasingly being used as an alternative to surgical reoperation. Here we report the successful transapical transcatheter mitral valve-in-valve implantations of J-Valves in 3 patients with high risk of mitral bioprostheses failure. All patients were discharged successfully, and the follow-up results were good 30 days after operation without major complication. For high-risk patients, transcatheter implantation of the J-valve is a feasible solution for the treatment of degenerated mitral bioprostheses.
Sections du résumé
BACKGROUND
Due to the widespread application of bioprosthetic valve in the treatment of mitral valve disease in recent years, the incidence of valve failure has increased significantly, which is facing the need of reoperation. For high-risk patients, transcatheter mitral valve-in-valve placement is increasingly being used as an alternative to surgical reoperation.
CASE PRESENTATION
Here we report the successful transapical transcatheter mitral valve-in-valve implantations of J-Valves in 3 patients with high risk of mitral bioprostheses failure. All patients were discharged successfully, and the follow-up results were good 30 days after operation without major complication.
CONCLUSIONS
For high-risk patients, transcatheter implantation of the J-valve is a feasible solution for the treatment of degenerated mitral bioprostheses.
Identifiants
pubmed: 37563738
doi: 10.1186/s12872-023-03414-5
pii: 10.1186/s12872-023-03414-5
pmc: PMC10416433
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
395Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Alkhouli M, Alqahtani F, Simard T, Pislaru S, Schaff HV, Nishimura RA. Predictors of use and outcomes of mechanical valve replacement in the United States (2008–2017). J Am Heart Assoc. 2021;10(9):e019929.
doi: 10.1161/JAHA.120.019929
pubmed: 33870704
pmcid: 8200758
Thourani VH, Weintraub WS, Guyton RA, Jones EL, Williams WH, Elkabbani S, et al. Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting. Circulation. 2003;108:298–304. https://doi.org/10.1161/01.CIR.0000079169.15862.13 .
doi: 10.1161/01.CIR.0000079169.15862.13
pubmed: 12835220
Jones JM, O’Kane H, Gladstone DJ, Sarsam MA, Campalani G, MacGowan SW, et al. Repeat heart valve surgery: risk factors for operative mortality. J Thorac Cardiovasc Surg. 2001;122:913–8. https://doi.org/10.1067/mtc.2001.116470 .
doi: 10.1067/mtc.2001.116470
pubmed: 11689796
Jamieson WR, Burr LH, Miyagishima RT, Janusz MT, Fradet GJ, Lichtenstein SV, et al. Reoperation for bioprosthetic mitral structural failure: risk assessment. Circulation. 2003;108(Suppl 1):II98–102. https://doi.org/10.1161/01.cir.0000089184.46999.f4 .
doi: 10.1161/01.cir.0000089184.46999.f4
pubmed: 12970216
Writing Committee M, Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the american college of cardiology/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2021;77:e25–197. https://doi.org/10.1016/j.jacc.2020.11.018 .
doi: 10.1016/j.jacc.2020.11.018
Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91. https://doi.org/10.1093/eurheartj/ehx391 .
doi: 10.1093/eurheartj/ehx391
pubmed: 28886619
Whisenant B, Kapadia SR, Eleid MF, et al. One-year outcomes of mitral valve-in-valve using the SAPIEN 3 Transcatheter Heart Valve. JAMA Cardiol. 2020;5:1245–52.
doi: 10.1001/jamacardio.2020.2974
pubmed: 32745164
pmcid: 7391176
Liu X, Tang Y, Luo F, Tian Y, Li K, Sun J, et al. Transapical implantation of a self-expandable aortic valve prosthesis utilizing a novel designed positioning element. Catheter Cardiovasc Interv. 2017;89:E30–7. https://doi.org/10.1002/ccd.26429 .
doi: 10.1002/ccd.26429
pubmed: 26811261
Lu Y et al. Yang Ye,Wang Wenshuo. Transcatheter Mitral Valve-in-Valve Implantation With a New Transcatheter Heart Valve for Bioprosthetic Degeneration.[J].Front Cardiovasc Med. 2021;8:783507.
Ribeiro HB, Nombela-Franco L, Muñoz-García AJ, et al. Predictors and impact of myocardial injury after transcatheter aortic valve replacement a multicenter registry. J Am Coll Cardiol. 2015;66(19):2075–88. https://doi.org/10.1016/j.jacc.2015.08.881 .
doi: 10.1016/j.jacc.2015.08.881
pubmed: 26541917
Nazir S, Lohani S, Tachamo N, et al. Outcomes following transcatheter transseptal versus transapical mitral valve-in-valve and valve-in-ring procedures. J Cardiovasc Thorac Res. 2018;10(4):182–6. https://doi.org/10.15171/jcvtr.2018.31 .
doi: 10.15171/jcvtr.2018.31
pubmed: 30680074
pmcid: 6335986
Wei Peijian M, Jiexu T, Tong X, Nianjin C, Zhao Z Yuyuan., Hongxiang L, Jian C, Guo Huiming. (2021). A novel alternative: transapical transcatheter mitral valve-in-valve implantation using J-Valve for failed bioprosthesis. J Thorac Dis. 13(8):5055–5063. https://doi.org/10.21037/jtd-21-975 .